More on the News In the past year, shares of DGX have risen by 3% compared with the industry's growth of 11.5%. Industry Prospects Estimates for DaVita's 2024 earnings per share have remained constant at $9.62 in the past 30 days. Shares of the company have surged 35.4% in the past year compared with the industry's 11.5% growth. Quest Diagnostics (DGX) recently announced a definitive agreement to purchase the select assets of OhioHealth's outreach laboratory services business. The transaction will expand ac ...